St Andrews Research Repository

St Andrews University Home
View Item 
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  • Register / Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis

Thumbnail
View/Open
Feasey_2013_JCM_XpertMTBRIF_CC.pdf (429.7Kb)
Date
15/05/2013
Author
Feasey, Nicholas A.
Banada, Padmapriya P.
Howson, William
Sloan, Derek J.
Mdolo, Aaron
Boehme, Catharina
Chipungu, Geoffrey A.
Allain, Theresa J.
Heyderman, Robert S.
Corbett, Elizabeth L.
Alland, David
Keywords
RA0421 Public health. Hygiene. Preventive Medicine
Microbiology (medical)
Medicine(all)
SDG 3 - Good Health and Well-being
Metadata
Show full item record
Abstract
Tuberculosis (TB) remains a leading cause of death among HIV-infected adults, in part because of delayed diagnosis and therefore delayed initiation of treatment. Recently, the Gene-Xpert platform, a rapid, PCR-based diagnostic platform, has been validated for the diagnosis of TB with sputum. We have evaluated the Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis bacteremia and investigated its impact on clinical outcomes. Consecutive HIV-infected adults with fever and cough presenting to Queen Elizabeth Central Hospital, Blantyre, Malawi, were recruited and followed up for 2 months. At presentation, three sputum samples were examined by smear, culture, and Xpert MTB/RIF assay for the presence of M. tuberculosis and blood was drawn for PCR with Xpert, for mycobacterial culture (Myco/F Lytic), and for aerobic culture. One hundred four patients were recruited, and 44 (43%) were sputum culture positive for M. tuberculosis. Ten were Xpert blood positive, for a sensitivity of 21% and a specificity of 100%. The 2-week mortality rate was significantly higher among patients who were Xpert blood positive than among those who were negative (40% versus 3%; multivariate odds ratio [OR] for death if positive, 44; 95% confidence interval [CI], 3 to 662). This effect persisted on assessment of the mortality rate at 2 months (40% versus 11%; OR, 5.6; 95% CI, 1.3 to 24.6). When screening uncomplicated patients presenting with a productive cough for pulmonary TB, Xpert blood offers no diagnostic advantage over sputum testing. Despite this, Xpert blood positivity is highly predictive of early death and this test rapidly identifies a group of patients in urgent need of initiation of treatment.
Citation
Feasey , N A , Banada , P P , Howson , W , Sloan , D J , Mdolo , A , Boehme , C , Chipungu , G A , Allain , T J , Heyderman , R S , Corbett , E L & Alland , D 2013 , ' Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis ' , Journal of Clinical Microbiology , vol. 51 , no. 7 , pp. 2311-2316 . https://doi.org/10.1128/JCM.00330-13
Publication
Journal of Clinical Microbiology
Status
Peer reviewed
DOI
https://doi.org/10.1128/JCM.00330-13
ISSN
0095-1137
Type
Journal article
Rights
Copyright © 2013 Feasey et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.
Description
The Foundation for Innovative New Diagnostics supported this study financially and had a role in its design, data interpretation, and writing of the manuscript (C.B.). N.A.F. and D.A. had full access to all study data and, in consultation with the rest of us, made the final decision to submit this work for publication. N.A.F. was funded by a Wellcome Research Training Fellowship. The surveillance service for invasive bacterial infections at the Malawi-Liverpool Wellcome Trust is supported by a Wellcome Trust Major Overseas Program award (084679/Z/08/Z).
Collections
  • University of St Andrews Research
URI
http://hdl.handle.net/10023/13033

Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

Advanced Search

Browse

All of RepositoryCommunities & CollectionsBy Issue DateNamesTitlesSubjectsClassificationTypeFunderThis CollectionBy Issue DateNamesTitlesSubjectsClassificationTypeFunder

My Account

Login

Open Access

To find out how you can benefit from open access to research, see our library web pages and Open Access blog. For open access help contact: openaccess@st-andrews.ac.uk.

Accessibility

Read our Accessibility statement.

How to submit research papers

The full text of research papers can be submitted to the repository via Pure, the University's research information system. For help see our guide: How to deposit in Pure.

Electronic thesis deposit

Help with deposit.

Repository help

For repository help contact: Digital-Repository@st-andrews.ac.uk.

Give Feedback

Cookie policy

This site may use cookies. Please see Terms and Conditions.

Usage statistics

COUNTER-compliant statistics on downloads from the repository are available from the IRUS-UK Service. Contact us for information.

© University of St Andrews Library

University of St Andrews is a charity registered in Scotland, No SC013532.

  • Facebook
  • Twitter